First Use of the Molecular Adsorbent Recirculating System Technique on Patients with Hypoxic Liver Failure After Cardiogenic Shock

@article{Banayosy2004FirstUO,
  title={First Use of the Molecular Adsorbent Recirculating System Technique on Patients with Hypoxic Liver Failure After Cardiogenic Shock},
  author={A. M. El Banayosy and Lukasz Kizner and Victor J. Schueler and S. Bergmeier and Dagmar Cobaugh and Reiner Koerfer},
  journal={ASAIO Journal},
  year={2004},
  volume={50},
  pages={332-337}
}
The Molecular Adsorbent Recirculating System (MARS) has been proven to prolong survival in patients with hepatorenal syndrome. MARS is a modified dialysis that uses an albumin containing dialysate, which is recirculated and perfused online through charcoal and anion exchanger columns. It allows the selective removal of albumin bound substances.Despite advances in medical therapy and technology, the prognosis of patients with cardiogenic shock remains poor. Mortality rates are as high as 80… 
Extracorporeal membrane oxygenation with multiple-organ failure: Can molecular adsorbent recirculating system therapy improve survival?
  • B. Sparks, N. Cavarocchi, H. Hirose
  • Medicine
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2017
TLDR
MARS therapy in patients on ECMO safely accelerated recovery of liver function and improved survival to wean from ECMO, without increasing complications.
Commentary The Molecular Adsorbent Recirculating System (MARS ® ) in the intensive care unit: a rescue therapy for patients with hepatic
TLDR
It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.
The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure
TLDR
It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.
The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children
TLDR
The benefits of extracorporeal liver support systems need to be balanced against the costs and the risk of volume and nitrogen overload if repeated plasma infusion is required, and plasma exchange in combination with hemodialysis should be preferred.
The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients *
TLDR
MARS treatment might partly explain the trend toward increased survival of ALF patients with unknown etiology, and Interpretation of the results was difficult in toxic etiology patients on account of differing baseline statuses.
Molecular adsorbent recirculating system technique for liver failure due to cardiogenic shock.
TLDR
Inhospital mortality is still unsatisfyingly high in cardiogenic shock patients with liver failure and future studies should clarify whether MARS can definitively improve survival in these patients.
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
Extracorporeal liver support has been a much studied topic throughout the last 50 years. Albumin dialysis as a therapeutic option for patients with acute liver failure or acute decompensation of
Survival predictors in patients treated with a molecular adsorbent recirculating system.
TLDR
MARS treatment appears to be ineffective in AOCLF with end-stage cirrhosis without an LTX option, and the etiology of liver disease was the most important prognostic factor.
Bench-to-bedside review: Current evidence for extracorporeal albumin dialysis systems in liver failure
TLDR
Although MARS and Prometheus have shown biochemical improvements in AoCLF and ALF, additional studies are required to show conclusive benefit in short- and long-term survival, and the appropriate comparator is standard medical therapy rather than head-to-head comparisons of different forms of albumin dialysis.
Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation
TLDR
Together, albumin dialysis represents a valuable therapeutic tool for the treatment of various types of liver failure and ongoing and future studies will help define the optimal patient selection and technical process parameters such as session length and frequency of treatment.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 18 REFERENCES
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
TLDR
It is concluded that the molecular adsorbent recirculating system can contribute to the treatment of critically ill patients with liver failure and different underlying diseases.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, +14 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.
TLDR
A new membrane separation system that is nearly impermeable to proteins but enables the exchange of water soluble and protein bound toxins by a special membrane and a recycled protein containing dialysate is described.
Characteristics of an Albumin Dialysate Hemodiafiltration System for the Clearance of Unconjugated Bilirubin
TLDR
The clearance of unconjugated bilirubin is greatly enhanced with the use of albumin containing dialysates when compared to traditional crystalloid hemodiafiltration, is greater at lower pH, and seems to be unaffected by temperature.
Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?
TLDR
An ECLVS utilizing hemodiafiltration with albumin dialysis is more effective than conventional hemofiltration in the clearance of TNF-alpha and IL-6 and, therefore, may benefit patients with acute hepatic failure.
A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver
TLDR
The presented hybrid membrane may be used like an “intellegent membrane” as a safety barrier between the patients blood and cell devices and a significant reduction of protein bound toxins and a transport of metabolically relevant solutes, like amino acids, was shown.
The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group.
TLDR
Left ventricular function, as reflected byleft ventricular ejection fraction and severity of left ventricular wall motion abnormality, was the most important determinant of in-hospital mortality in the patients with cardiogenic shock.
Review article: liver support systems in acute hepatic failure
  • Rahman, Hodgson
  • Medicine
    Alimentary pharmacology & therapeutics
  • 1999
TLDR
Advances in surgical techniques and pharmaceutical developments have led to the establishment of successful liver transplantation programmes, which have improved mortality significantly.
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group.
TLDR
A significant proportion of MI patients who developed cardiogenic shock during hospitalization were free of heart failure on admission, and several risk factors facilitating early identification of subgroups at risk for cardiogenesis shock within otherwise low-risk patients were identified.
Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.
TLDR
It is suggested that neither the incidence nor the prognosis of cardiogenic shock resulting from acute myocardial infarction has improved over time, and both in-hospital and long-term survival remain poor for patients with this complication.
...
1
2
...